Renal Denervation in Patients With Refractory Hypertension

Medtronic

Status: Completed

Conditions: Hypertension

Treatments: Device: Renal Denervation

Study type: Interventional

Funder types: Industry

Identifiers

NCT00753285

TP-040

Details and patient eligibility

About

The purpose of this study is to investigate the clinical utility of renal denervation for the treatment of refractory hypertension.

Enrollment: 35 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Systolic blood pressure of 160 mmHg or greater
• On 3 or more antihypertensive medications
• eGFR >= 45 mL/min

Exclusion criteria

• Renal artery abnormalities
• Known secondary hypertension attributable to a cause other than sleep apnea
• MI, angina, CVA within 6 months
• Type 1 diabetes
• Others

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

35 participants in 1 patient group

Renal Denervation

Experimental group

Treatment:

Device: Renal Denervation